Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed?

Adjuvant tamoxifen for pre- and postmenopausal women with estrogen receptor positive, node positive breast cancer: A randomized study

Breast Cancer Research and Treatment ◽

10.1007/bf00690184 ◽

1995 ◽

Vol 36 (1) ◽

pp. 49-53 ◽

Cited By ~ 14

Author(s):

S. Gundersen ◽

E. Hannisdal ◽

J. A. S�reide ◽

A. Skarstein ◽

J. E. Varhaug

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Postmenopausal Women ◽

Randomized Study ◽

Positive Node ◽

Adjuvant Tamoxifen ◽

Node Positive ◽

Aromatase inhibitors versus tamoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies.

10.1158/0008-5472.sabcs-12 ◽

2009 ◽

Cited By ~ 17

Author(s):

JN Ingle ◽

M Dowsett ◽

J Cuzick ◽

C Davies

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Adjuvant Therapy ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Randomized Trials ◽

Meta Analyses ◽

Switching Strategies ◽

Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer

Cancer Research ◽

10.1158/0008-5472.can-08-2989 ◽

2009 ◽

Vol 69 (10) ◽

pp. 4184-4191 ◽

Cited By ~ 26

Author(s):

Angela DeMichele ◽

Robert Gray ◽

Michelle Horn ◽

Jinbo Chen ◽

Richard Aplenc ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Interleukin 6 ◽

Genetic Variants ◽

Positive Node ◽

Node Positive ◽

Poor Outcome ◽

Host Genetic ◽

DNA methylation marker and prediction of outcome in node-positive, estrogen-receptor positive breast cancer patients receiving adjuvant anthracyclin-based chemotherapy

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.11046 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 11046-11046

Author(s):

J. W. Martens ◽

O. Hartmann ◽

F. Spyratos ◽

N. Harbeck ◽

M. Schmitt ◽

...

Keyword(s):

Breast Cancer ◽

Dna Methylation ◽

Estrogen Receptor ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Prediction Of Outcome ◽

Methylation Marker ◽

Node Positive ◽

Effect of 21-gene recurrence score results on treatment recommendations in patients age 65 and older with lymph node-positive, estrogen receptor-positive breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e11077 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e11077-e11077 ◽

Cited By ~ 1

Author(s):

R. Oratz ◽

C. Chao ◽

S. Skrzypczak ◽

C. Ory ◽

M. Broder

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Node ◽

Recurrence Score ◽

Treatment Recommendations ◽

Node Positive ◽

Lymph Node Positive ◽

Adjusting for covariates in evaluating markers for selecting treatment, with application to guiding chemotherapy for treating estrogen-receptor-positive, node-positive breast cancer

Contemporary Clinical Trials ◽

10.1016/j.cct.2017.08.004 ◽

2017 ◽

Vol 63 ◽

pp. 30-39 ◽

Cited By ~ 2

Author(s):

Holly Janes ◽

Marshall D. Brown ◽

Michael R. Crager ◽

Dave P. Miller ◽

William E. Barlow

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Positive Node ◽

Node Positive ◽

Practice Patterns in Surgery and Adjuvant Therapy for Men Age 70 Years and Older with Early Stage, Estrogen-Receptor Positive Breast Cancer: Is CALGB 9343 Being Applied?

Journal of the American College of Surgeons ◽

10.1016/j.jamcollsurg.2020.07.019 ◽

2020 ◽

Vol 231 (4) ◽

pp. S40

Author(s):

Austin D. Williams ◽

Robin M. Ciocca ◽

Jennifer L. Sabol ◽

Ned Zachary Carp

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Adjuvant Therapy ◽

Practice Patterns ◽

Early Stage ◽

DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-08-0166 ◽

2008 ◽

Vol 15 (1) ◽

pp. 315-323 ◽

Cited By ~ 72

Author(s):

Oliver Hartmann ◽

Frédérique Spyratos ◽

Nadia Harbeck ◽

Dimo Dietrich ◽

Anne Fassbender ◽

...

Keyword(s):

Breast Cancer ◽

Dna Methylation ◽

Estrogen Receptor ◽

Node Positive ◽

Meta-Analysis of Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy in Postmenopausal Women with Estrogen Receptor–Positive, Node-Positive Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2001.n.018 ◽

2001 ◽

Vol 2 (2) ◽

pp. 138-143 ◽

Cited By ~ 14

Author(s):

Anne-Renee Hartman ◽

Gini F. Fleming ◽

John J. Dillon

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Postmenopausal Women ◽

Meta Analysis ◽

Positive Node ◽

Node Positive ◽

Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer

Clinical & Translational Oncology ◽

10.1007/s12094-006-0180-z ◽

2006 ◽

Vol 8 (5) ◽

pp. 339-348 ◽

Cited By ~ 14

Author(s):

Juan Miguel Gil ◽

Carlos Rubio-Terrés ◽

Almudena del Castillo ◽

Paloma González ◽

Felisa Canorea

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Adjuvant Therapy ◽

Postmenopausal Women ◽

Pharmacoeconomic Analysis ◽